Fundraising Fox

Mitchell Keegan

Chief Development Officer at Normunity

Cambridge, Massachusetts, United States

Find your path to Mitchell

88 people in our graph share verified history with Mitchell — schools, employers, funds. One of them is your warm intro.

Gretchen McCareyunlockedMitchell: together at Boston Pharmaceuticals (2016–2021)
×3Mitchell: together at University of Sydney
×6Mitchell: together at University of Western Sydney
Mitchell: together at Boston Pharmaceuticals

Chief Development Officer at Normunity

Intro paths

→

In turn, Mitchell can intro founders to Normunity's investors below.

Normunity's investors · 10

Canaan PartnersStamford · $500K – $20M checks · since 2025Connecticut InnovationsNew Haven · $500K – $2M checks · since 2025HongShan Capital GroupHong Kong · $100K – $50M checks · since 2025Osage Venture PartnersBala Cynwyd · $500K – $3M checks · since 2025Pfizer Venture Investments$5M – $20M checksPfizer Venturessince 2025Samsara BioCapitalPalo Alto · since 2025Sanofi VenturesCambridge · $5M checks · since 2025Taiho Ventures, LLCMenlo Park · since 2025YK BioventuresBurlingame · since 2025

Co-founders at Normunity

RHRachel Humphrey
Rachel HumphreyFounding Chief Executive Officer
LC
Lieping ChenScientific Founder

Experience

  1. NormunityChief Development Officercurrent2026 — presentBoston, Massachusetts, United States
  2. Hillstar BioChief Development Officer2024 — 2025Boston, Massachusetts, United States
  3. Boston PharmaceuticalsSenior Vice President, Clinical Development & Head of Research & Development Strategic Planning2021 — 2023
  4. Boston PharmaceuticalsSenior Vice President, Clinical Development & Head of Clinical Operations2019 — 2021
  5. Boston PharmaceuticalsVice President, Clinical Development2016 — 2019
  6. VerastemVice President, Clinical Development2011 — 2015Needham MA
  7. CurisVice President, Drug Development2008 — 2011
  8. Gloucester PharmaceuticalsSenior Director, Drug Development2005 — 2008
  9. CombinatoRxDirector, Pharmacology2001 — 2005
  10. Toxikon CorporationStudy Director2001
  11. Harvard Medical School/Josling Diabetes CenterResearch Fellow in Medicine1998 — 2001

Skills & more

Regulatory RequirementsLeadershipClinical StrategyDevelopment ProgramsDrug DevelopmentTeam ManagementResearch and Development (R&D)PharmacologyCMC developmentProgram ManagementMedical MonitoringClinical Study Design
+3 moreClinical OperationsRegulatory AffairsOncology Clinical Research

From Mitchell's professional profile.

Frequently asked questions

Who is Mitchell Keegan?
Chief Development Officer at Normunity
Where does Mitchell Keegan work?
Mitchell Keegan is Chief Development Officer at Normunity.
Where did Mitchell Keegan go to school?
Mitchell Keegan studied at Commonwealth Industrial & Scientific Research Organization, Australia (Postgraduate Student/Research Scientist); University of Western Sydney (Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology); University of Sydney (Bachelor of Science (1st class Honors), Biochemistry and Genetics).

Same school

Also attended University of Western Sydney45

Diego GourguesChief Financial Officer at Stoic VCPercy ChauData Analyst at The Spartan GroupChris KingDeputy General Counsel at Comcast VenturesAndrew BotrosChief Financial Officer at InVitro CapitalStephanie HamlynInvestment Manager at Partners for GrowthAlan BurtInvestor at Beachhead Venture Capital

+ 39 more

Also attended University of Sydney454

Clay RobbinsForward Deployed Partner at Slow VenturesClare McCartney BeerCOO & Managing Director at Burda Principal InvestmentsTony NystenPartner at OpenOceanGustav von SydowInvestor at EQT VenturesNaomi GunasekaranDeputy Chief Financial Officer, Funds - Finance at Magnetar AI VenturesAlex ChetkowskiInvestor at Riverwood Capital

+ 448 more

Shared employers

Also worked at Normunity7

MegInvestor at Sanofi VenturesPaulina HillPartner at Sanofi VenturesHidefumi KasugaInvestment Director at Taiho Ventures, LLCMarie-Claire PeakmanExecutive Director, WWBD / Partner at Pfizer Venture InvestmentsRachel HumphreyFounding Chief Executive Officer at NormunityWilliam LaRochelleChief Scientific Officer at Normunity

+ 1 more

Also worked at Hillstar Bio2

Lauren MifflinPrincipal of Company Creation at Frazier Life SciencesSamantha BerrickExecutive Assistant at Frazier Life Sciences

Also worked at Boston Pharmaceuticals5

Gretchen McCareyChief Financial Officer at Castle Island VenturesAnkur ShahVice President, CCD at AbingworthChristoph BrojaPartner at EQT Life SciencesPeter AgnesOperating Partner, B-Flexion Life Sciences at B-FLEXIONCraig BassonChief Medical Officer, President of R&D at Variant Bio

Also worked at Verastem7

AMY C. CAVERSExecutive Officer at VerastemCATHY CAREWExecutive Officer at VerastemJONATHAN PACHTERExecutive Officer at VerastemBRIAN STUGLIKExecutive Officer, Director at VerastemJOANNA HOROBINExecutive Officer at VerastemAnne FornicolaVice President of Chemistry, Manufacturing and Controls at On Target Laboratories

+ 1 more